Aviva Holdings Ltd.’s Esperion Therapeutics Inc Ne Position
Does Aviva Holdings Ltd. own Esperion Therapeutics Inc Ne (ESPR)? Not currently — the last reported position was 441.6K shares worth $18M in Q1 2019; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$18M
Q1 2019
Shares
441.6K
% of Portfolio
+3.89%
Quarters Held
2
position exited
Position History ESPR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aviva Holdings Ltd.’s full portfolio or all institutional holders of ESPR.